FMS250117C20000
- 2.10
- 0.000.00%
Fresenius Medical Care Newsroom
J.P. Morgan Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Jefferies Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Zacks Value Investor Highlights: Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care
MWB Research Cuts Fresenius to Sell Amid DAX-Driven Overvaluation
Truist Financial Maintains Fresenius Medical Care(FMS.US) With Hold Rating, Raises Target Price to $25
Truist Securities Maintains Hold on Fresenius Medical Care, Raises Price Target to $25
Express News | FMC AG : Truist Securities Raises Target Price to $25 From $23
Is Now The Time To Look At Buying Fresenius Medical Care AG (ETR:FME)?
Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index
Fresenius Medical Care Returns to Dax 40 Index
Cara Jumps on All-stock Merger Deal With Tvardi
Fresenius Medical Care Announces Release of Bond Guarantee
Cara Therapeutics: Also Enters Into an Asset Purchase Agreement With Vifor Fresenius Medical Care Renal Pharma >CARA
Zacks.com Featured Highlights Tyson Foods, General Motors, Fresenius Medical Care and Deluxe
4 Value Stocks to Buy as Wall Street Awaits Fed's Rate Decision
Leadership in Dialysis Services and Products Drives FMS Stock
Hugo Boss Proposes Stephan Sturm as Chairman of the Supervisory Board
Fresenius Medical Care Resolves Legal Proceedings on Company Restructuring
Institutional Investors Control 42% of Fresenius Medical Care AG (ETR:FME) and Were Rewarded Last Week After Stock Increased 6.1%
Berenberg Bank Keeps Their Buy Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)